Cargando…

Efficient Removal of Non-Structural Protein Using Chloroform for Foot-and-Mouth Disease Vaccine Production

To differentiate foot-and-mouth disease (FMD)-infected animals from vaccinated livestock, non-structural proteins (NSPs) must be removed during the FMD vaccine manufacturing process. Currently, NSPs cannot be selectively removed from FMD virus (FMDV) culture supernatant. Therefore, polyethylene glyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sun Young, Lee, Jung-Min, Kim, Ah-Young, Park, Sang Hyun, Lee, Sim-In, Kim, Hyejin, Kim, Jae-Seok, Park, Jong-Hyeon, Ko, Young-Joon, Park, Choi-Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565013/ https://www.ncbi.nlm.nih.gov/pubmed/32867254 http://dx.doi.org/10.3390/vaccines8030483

Ejemplares similares

Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens
por: Park, Sun Young, et al.
Publicado: (2022)

Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5
por: Kim, Hyejin, et al.
Publicado: (2021)

Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2021)

Application of Heparin Affinity Chromatography to Produce a Differential Vaccine without Eliciting Antibodies against the Nonstructural Proteins of the Serotype O Foot-and-Mouth Disease Viruses
por: Park, Sun Young, et al.
Publicado: (2020)

Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs
por: Park, Sang-Hyun, et al.
Publicado: (2021)

Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate
por: LEE, Hyang-Sim, et al.
Publicado: (2020)

Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2021)

Comparison of High-Performance Liquid Chromatography with Sucrose Density Gradient Ultracentrifugation for the Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2022)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
por: Park, Sun Young, et al.
Publicado: (2022)

Efficacy of Binary Ethylenimine in the Inactivation of Foot-and-Mouth Disease Virus for Vaccine Production in South Korea
por: Kim, Jae Young, et al.
Publicado: (2023)

Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A
por: Kim, Dong-Wan, et al.
Publicado: (2023)

Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents
por: Kim, Su-Mi, et al.
Publicado: (2012)

Reemergence of Foot-and-Mouth Disease, South Korea, 2000–2011
por: Park, Jong-Hyeon, et al.
Publicado: (2014)

Production of Foot-and-Mouth Disease Type O and A Vaccine Antigens on a Pilot Scale and Determination of Optimal Amount of Antigen for Monovalent Vaccines
por: Kim, Jae Young, et al.
Publicado: (2023)

Determination of optimal age for single vaccination of growing pigs with foot-and-mouth disease bivalent vaccine in South Korea
por: KIM, Ah-Young, et al.
Publicado: (2017)

Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses
por: Lee, Seo-Yong, et al.
Publicado: (2017)

Novel foot-and-mouth disease virus in Korea, July-August 2014
por: Park, Jong-Hyeon, et al.
Publicado: (2016)

Control of Foot-and-Mouth Disease during 2010–2011 Epidemic, South Korea
por: Park, Jong-Hyeon, et al.
Publicado: (2013)

Production of a Foot-and-Mouth Disease Vaccine Antigen Using Suspension-Adapted BHK-21 Cells in a Bioreactor
por: Park, Soonyong, et al.
Publicado: (2021)

Transmission of Seasonal Outbreak of Childhood Enteroviral Aseptic Meningitis and Hand-foot-mouth Disease
por: Park, Sue K., et al.
Publicado: (2010)

Control of type O foot-and-mouth disease by vaccination in Korea, 2014–2015
por: Park, Jong-Hyeon, et al.
Publicado: (2018)

Antigenic properties and virulence of foot-and-mouth disease virus rescued from full-length cDNA clone of serotype O, typical vaccine strain
por: Kim, Rae-Hyung, et al.
Publicado: (2015)

The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine
por: Ko, Mi-Kyeong, et al.
Publicado: (2023)

Enteroviruses isolated from herpangina and hand-foot-and-mouth disease in Korean children
por: Park, KwiSung, et al.
Publicado: (2012)

Bovine Genome-wide Association Study for Genetic Elements to Resist the Infection of Foot-and-mouth Disease in the Field
por: Lee, Bo-Young, et al.
Publicado: (2015)

Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses
por: Lee, Min Ja, et al.
Publicado: (2020)

Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes
por: Park, Jong Hyeon, et al.
Publicado: (2006)

Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine
por: Park, Min-Eun, et al.
Publicado: (2017)

Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O
por: Hwang, Seong Yun, et al.
Publicado: (2023)

Requirements for improved vaccines against foot-and-mouth disease epidemics
por: Park, Jong-Hyeon
Publicado: (2013)

Synergistic effect of ribavirin and vaccine for protection during early infection stage of foot-and-mouth disease
por: Choi, Joo-Hyung, et al.
Publicado: (2018)

Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice
por: Bae, Ji-young, et al.
Publicado: (2009)

The Potential Adjuvanticity of CAvant(®)SOE for Foot-and-Mouth Disease Vaccine
por: Ahn, Young-Hoon, et al.
Publicado: (2021)

Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease
por: Shin, Seokwon, et al.
Publicado: (2023)

Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs
por: Hwang, Ji-Hyeon, et al.
Publicado: (2019)

Complete Genome Sequence of a Foot-and-Mouth Disease Virus of Serotype O, Isolated from Gochang, Republic of Korea, in 2016
por: Kim, Taeseong, et al.
Publicado: (2017)

Complete Genome Sequence of a Foot-and-Mouth Disease Virus of Serotype O Isolated from Gimje, Republic of Korea, in 2016
por: Ryoo, Soyoon, et al.
Publicado: (2017)

Preventive effects of quercetin against foot-and-mouth disease virus in vitro and in vivo by inducing type I interferon
por: Lee, Gyeongmin, et al.
Publicado: (2023)

Age-Dependent Dynamics of Maternally Derived Antibodies (MDAs) and Understanding MDA-Mediated Immune Tolerance in Foot-and-Mouth Disease-Vaccinated Pigs
por: Shin, Sehee, et al.
Publicado: (2022)

Analysis of Amino Acid Mutations of the Foot-and-Mouth Disease Virus Serotype O Using both Heparan Sulfate and JMJD6 Receptors
por: Lee, Gyeongmin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_glvpb5q49u2d0pq3pdqjsdqm1m